Smith Group Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,190
| Closed | -$20K | – | 278 |
|
|
2021
Q4 | $20K | Hold |
4,190
| – | – | ﹤0.01% | 253 |
|
|
2021
Q3 | $22K | Hold |
4,190
| – | – | ﹤0.01% | 229 |
|
|
2021
Q2 | $21K | Buy |
4,190
+1,200
| +40% | +$6.01K | ﹤0.01% | 230 |
|
|
2021
Q1 | $20K | Sell |
2,990
-69,640
| -96% | -$466K | ﹤0.01% | 207 |
|
|
2020
Q4 | $332K | Sell |
72,630
-101,130
| -58% | -$462K | 0.02% | 154 |
|
|
2020
Q3 | $674K | Sell |
173,760
-60
| -0% | -$233 | 0.04% | 116 |
|
|
2020
Q2 | $827K | Buy |
+173,820
| New | +$827K | 0.05% | 108 |
|
|
2018
Q4 | – | Sell |
-110,980
| Closed | -$2.46M | – | 449 |
|
|
2018
Q3 | $2.46M | Buy |
+110,980
| New | +$2.46M | 0.07% | 121 |
|